Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.61 (
porphobilinogen deaminase
)
637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
All eight enzymes required for de novo heme biosynthesis have been predicted from the nuclear genome of the human
malaria
parasite Plasmodium falciparum. We have studied the subcellular localization of three of these using a GFP reporter in live transfected parasites. The first enzyme in the pathway delta-aminolevulinic acid synthase (ALAS) is targeted to the mitochondrion, but the next two enzymes porphobilinogen synthase (PBGS) and
hydroxymethylbilane synthase
(
HMBS
) are targeted to the plastid. An enzymatically active recombinant version of PBGS from P. falciparum was over-expressed and its activity found to be stimulated by Mg2+ (and enhanced by Mn2+) but not by Zn2+. A hypothetical scheme for the exchange of intermediates in heme biosynthesis between the mitochondrion and plastid organelle, as well as organelle attachment is discussed.
...
PMID:Enzymes for heme biosynthesis are found in both the mitochondrion and plastid of the malaria parasite Plasmodium falciparum. 1514 63
An important component in host resistance to
malaria
infection are inherited mutations that give rise to abnormalities and deficiencies in erythrocyte proteins and enzymes. Understanding how such mutations confer protection against the disease may be useful for developing new treatment strategies. A mouse ENU-induced mutagenesis screen for novel
malaria
resistance-conferring mutations identified a novel non-sense mutation in the gene encoding
porphobilinogen deaminase
(
PBGD
) in mice, denoted here as
Pbgd
MRI
58155
. Heterozygote
Pbgd
MRI
58155
mice exhibited ~50% reduction in cellular
PBGD
activity in both mature erythrocytes and reticulocytes, although enzyme activity was ~10 times higher in reticulocytes than erythrocytes. When challenged with blood-stage
P. chabaudi
, which preferentially infects erythrocytes, heterozygote mice showed a modest but significant resistance to infection, including reduced parasite growth. A series of assays conducted to investigate the mechanism of resistance indicated that mutant erythrocyte invasion by
P. chabaudi
was normal, but that following intraerythrocytic establishment a significantly greater proportions of parasites died and therefore, affected their ability to propagate. The
Plasmodium
resistance phenotype was not recapitulated in
Pbgd
-deficient mice infected with
P. berghei
, which prefers reticulocytes, or when
P. falciparum
was cultured in erythrocytes from patients with acute intermittent porphyria (AIP), which had modest (20-50%) reduced levels of
PBGD
. Furthermore, the growth of
Pbgd
-null
P. falciparum
and
Pbgd
-null
P. berghei
parasites, which grew at the same rate as their wild-type counterparts in normal cells, were not affected by the
PBGD
-deficient background of the AIP erythrocytes or
Pbgd
-deficient mice. Our results confirm the dispensability of parasite
PBGD
for
P. berghei
infection and intraerythrocytic growth of
P. falciparum
, but for the first time identify a requirement for host erythrocyte
PBGD
by
P. chabaudi
during
in vivo
blood stage infection.
...
PMID:Host Porphobilinogen Deaminase Deficiency Confers Malaria Resistance in
Plasmodium chabaudi
but Not in
Plasmodium berghei
or
Plasmodium falciparum
During Intraerythrocytic Growth. 3301 90